Archives

img-01

Quick Asia Regulatory Updates (November 2025)

Singapore’s Health Sciences Authority (HSA) has strengthened international regulatory collaboration through two Memoranda of Understanding (MOUs) signed during the 16th International Conference on Medical Regulation 2025. On September 4, the HSA signed an MOU with Australia’s Therapeutic Goods Administration (TGA) to facilitate... Read More

img-01

Quick Asia Regulatory Updates (August 2025)

From July 14, 2025, Singapore’s Health Sciences Authority (HSA) will enforce a revised version of the guidance document GN-21 to streamline medical device change reporting. Low-risk changes such as label designs, new barcodes, and supplier changes do not need to be reported.... Read More

img-01

Drug Master File (DMF) Systems in Asia

Introduction Quality, safety, and efficacy are of the utmost importance for drug products. A vital part in achieving this is having a Drug Master File (DMF). A DMF is a confidential submission to a health authority to provide detailed information about the... Read More

img-01

Singapore Regulatory Updates

The Singapore Health Sciences Authority (HSA) has broadened its Singapore Health Product Access and Regulatory E-System (SHARE) to cover Class 2 Cell, Tissue, and Gene Therapy Products (CTGTP) as well as dealer licensing and certification applications. Starting February 10, 2025, stakeholders can use SHARE to better... Read More